M&T Bank Corp Teva Pharmaceutical Industries LTD Transaction History

M&T Bank Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$6.53 - $10.72 $197,878 - $324,848	-30,303 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$6.16 - $9.6 $10,200 - $15,897	-1,656 Reduced 5.18%	30,303 $208,000
Q2 2019 Aug 12, 2019	SELL	$8.12 - $15.72 $87,492 - $169,383	-10,775 Reduced 25.21%	31,959 $295,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $115,743 - $148,654	7,429 Added 21.04%	42,734 $669,000
Q4 2018 Feb 01, 2019	SELL	$14.59 - $23.84 $43,624 - $71,281	-2,990 Reduced 7.81%	35,305 $545,000
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $28,557 - $34,781	-1,356 Reduced 3.42%	38,295 $824,000
Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $15,394 - $22,683	918 Added 2.37%	39,651 $964,000
Q1 2018 May 04, 2018	SELL	$16.68 - $22.07 $1,050 - $1,390	-63 Reduced 0.16%	38,733 $662,000
Q4 2017 Feb 06, 2018	SELL	$11.23 - $19.1 $436,925 - $743,123	-38,907 Reduced 50.07%	38,796 $734,000
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $285,439 - $595,884	-18,523 Reduced 19.25%	77,703 $1.37 Million
Q2 2017 Aug 11, 2017	BUY	N/A	96,226	96,226 $3.2 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.